12-123692742-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024809.5(TCTN2):​c.1099+19T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.446 in 1,580,840 control chromosomes in the GnomAD database, including 165,446 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 20708 hom., cov: 32)
Exomes 𝑓: 0.44 ( 144738 hom. )

Consequence

TCTN2
NM_024809.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.336

Publications

24 publications found
Variant links:
Genes affected
TCTN2 (HGNC:25774): (tectonic family member 2) This gene encodes a type I membrane protein that belongs to the tectonic family. Studies in mice suggest that this protein may be involved in hedgehog signaling, and essential for ciliogenesis. Mutations in this gene are associated with Meckel syndrome type 8. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011]
TCTN2 Gene-Disease associations (from GenCC):
  • Joubert syndrome 24
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 12-123692742-T-C is Benign according to our data. Variant chr12-123692742-T-C is described in ClinVar as Benign. ClinVar VariationId is 126282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.715 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TCTN2NM_024809.5 linkc.1099+19T>C intron_variant Intron 9 of 17 ENST00000303372.7 NP_079085.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TCTN2ENST00000303372.7 linkc.1099+19T>C intron_variant Intron 9 of 17 1 NM_024809.5 ENSP00000304941.5

Frequencies

GnomAD3 genomes
AF:
0.499
AC:
75795
AN:
151990
Hom.:
20662
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.722
Gnomad AMI
AF:
0.552
Gnomad AMR
AF:
0.382
Gnomad ASJ
AF:
0.396
Gnomad EAS
AF:
0.150
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.347
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.448
Gnomad OTH
AF:
0.464
GnomAD2 exomes
AF:
0.414
AC:
103835
AN:
250978
AF XY:
0.419
show subpopulations
Gnomad AFR exome
AF:
0.731
Gnomad AMR exome
AF:
0.267
Gnomad ASJ exome
AF:
0.392
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.359
Gnomad NFE exome
AF:
0.448
Gnomad OTH exome
AF:
0.420
GnomAD4 exome
AF:
0.441
AC:
629875
AN:
1428732
Hom.:
144738
Cov.:
27
AF XY:
0.442
AC XY:
315382
AN XY:
712948
show subpopulations
African (AFR)
AF:
0.734
AC:
23957
AN:
32646
American (AMR)
AF:
0.281
AC:
12534
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.387
AC:
10037
AN:
25946
East Asian (EAS)
AF:
0.120
AC:
4759
AN:
39600
South Asian (SAS)
AF:
0.490
AC:
41941
AN:
85568
European-Finnish (FIN)
AF:
0.356
AC:
19005
AN:
53356
Middle Eastern (MID)
AF:
0.444
AC:
2405
AN:
5420
European-Non Finnish (NFE)
AF:
0.452
AC:
489156
AN:
1082272
Other (OTH)
AF:
0.440
AC:
26081
AN:
59256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
15142
30284
45426
60568
75710
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14406
28812
43218
57624
72030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.499
AC:
75890
AN:
152108
Hom.:
20708
Cov.:
32
AF XY:
0.491
AC XY:
36535
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.722
AC:
29946
AN:
41470
American (AMR)
AF:
0.382
AC:
5830
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
1371
AN:
3466
East Asian (EAS)
AF:
0.149
AC:
773
AN:
5178
South Asian (SAS)
AF:
0.462
AC:
2231
AN:
4826
European-Finnish (FIN)
AF:
0.347
AC:
3674
AN:
10588
Middle Eastern (MID)
AF:
0.462
AC:
135
AN:
292
European-Non Finnish (NFE)
AF:
0.448
AC:
30443
AN:
68002
Other (OTH)
AF:
0.467
AC:
985
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1776
3552
5329
7105
8881
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.455
Hom.:
69773
Bravo
AF:
0.506
Asia WGS
AF:
0.348
AC:
1214
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Meckel syndrome, type 8 Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joubert syndrome 24 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Meckel-Gruber syndrome;C0431399:Joubert syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.91
DANN
Benign
0.55
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7137946; hg19: chr12-124177289; API